The drug also had fewer side-effects when compared to chemotherapy, according to a trial. A once-daily pill helped almost double survival time for patients with an aggressive and advanced form of pancreatic cancer when compared to chemotherapy, a trial has found. The drug also caused fewer side-effects, with experts hailing daraxonrasib a... [3444 chars]
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
